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Abstract
Background: Health risks linked with dioxin in fish remain a complex policy issue. Fatty Baltic fish contain
persistent pollutants, but they are otherwise healthy food. We studied the health benefits and risks associated with
Baltic herring and salmon in four countries to identify critical uncertainties and to facilitate an evidence-based
discussion.
Methods: We performed an online survey investigating consumers’ fish consumption and its motivation in
Denmark, Estonia, Finland, and Sweden. Dioxin and methylmercury concentrations were estimated based on
Finnish studies. Exposure-response functions for several health endpoints were evaluated and quantified based on
the scientific literature. We also quantified the infertility risk of men based on a recent European risk assessment
estimating childhood dioxin exposure and its effect on sperm concentration later in life.
Results: Baltic herring and salmon contain omega-3 fatty acids and vitamin D, and the beneficial impact of these
fishes on cardiovascular diseases, mortality, and the risk of depression and cancer clearly outweighs risks of dioxins
and methylmercury in people older than 45 years of age and in young men. Young women may expose their
children to pollutants during pregnancy and breast feeding. This study suggests that even in this critical subgroup,
the risks are small and the health benefits are greater than or at least similar to the health risks. Value of
information analysis demonstrated that the remaining scientific uncertainties are not large. In contrast, there are
several critical uncertainties that are inherently value judgements, such as whether exceeding the tolerable weekly
intake is an adverse outcome as such; and whether or not subgroup-specific restrictions are problematic.
Conclusions: The potential health risks attributable to dioxins in Baltic fish have more than halved in the past 10
years. The new risk assessment issued by the European Food Safety Authority clearly increases the fraction of the
population exceeding the tolerable dioxin intake, but nonetheless, quantitative estimates of net health impacts
change only marginally. Increased use of small herring (which have less pollutants) is a no-regret option. A more
relevant value-based policy discussion rather than research is needed to clarify official recommendations related to
dioxins in fish.
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Background
Dioxins (polychlorinated dibenzo-p-dioxins and furans)
and polychlorinated biphenyls (PCBs) are persistent en-
vironmental pollutants that are found at relatively high
concentrations in fish [1]. Fatty Baltic fish (such as Baltic
herring, salmon, trout and lamprey) biomagnify dioxins
and PCBs in the food chain; e.g. they constitute the lar-
gest exposure source of these compounds in the Finnish
population [2]. These fish species often exceed the EU
limits for dioxins and PCBs [3], but Finland and Sweden
have a permanent derogation to sell these fish species on
their national markets; Latvia has a derogation for sal-
mon [4]. In contrast, Estonia deals with dioxins by
selecting small Baltic herring with lower concentrations
of pollutants for human consumption [5].
The EU has had a long-term objective of reducing hu-
man exposure to these pollutants. Emission standards
for industry have become stricter during recent decades,
and also concentration limits for food and feed have
eliminated the most badly contaminated items from the
market. Although average exposure has decreased to a
fraction of previous values, there are still concerns about
the health effects of dioxins, especially related to fatty
fish from the Baltic Sea.
The European Commission therefore asked the Euro-
pean Food Safety Authority (EFSA) to perform a risk as-
sessment and derive an updated tolerable weekly intake
(TWI) for dioxins and dioxin-like PCBs. The TWI was
recently published, and it is seven times lower (2 pg/kg/
week) than the previous value (14 pg/kg/week) [6].
Although previous benefit-risk assessments have been
published about Baltic fish [7], there are no studies that
would have compared several countries and examined
the reasons and motivations for fish eating (or fish
avoidance).
The BONUS GOHERR project (2015–2018) evaluated
the particular question about dioxins in Baltic salmon
and herring and performed a health benefit-risk assess-
ment, which is reported here. The project also studied
biological, socio-economic, cultural, and food security
aspects of the dioxin problem associated with the Baltic
salmon and herring fisheries and the governance of the
dioxin problem.
Methods
Modelling
The overall aim of the study was to estimate health risks
and benefits of important compounds (dioxins, dioxin-
like PCBs, methylmercury, omega-3 fatty acids [consist-
ing of eicosapentaenic acid EPA and docosahexaenic
acid DHA], and vitamin D) found in Baltic herring and
salmon in the current situation. The assessment model
was implemented in an open and modular way at Opas-
net web-workspace (en.opasnet.org). In practice, this
means that all the data and codes used for different
parts, or modules, of the model are located on different
pages at Opasnet. These pages are called knowledge
crystals, as their structure and workflow follow certain
rules (Tuomisto et al. 2019, forthcoming). In this sec-
tion, we provide an overview of the model and describe
the input data and assumptions used; the Results section
consists of the results obtained with the model. Links to
the module pages and all details can be found in the as-
sessment page [8]. The whole model with data and codes
is available on the page and also at Open Science Frame-
work research data repository [9].
The benefit-risk assessment was based on a modular
Monte Carlo simulation model, which had a hierarchical
Bayesian module for estimating dioxin concentrations.
The different modules are briefly described below, with
references and links to further material.
The input distributions were derived either directly
from data or from scientific publications. If no published
information was available (e.g. as was the case with dis-
ability weights for non-typical endpoints such as toler-
able weekly intakes or infertility), we used author
judgement and wide uncertainty bounds (these judge-
ments are described later in the text). The model was
run with 3000 iterations using R statistical software (ver-
sion 3.5.3, https://cran.r-project.org).
Consumption survey
The data used were from an internet-based survey that
was conducted at the end of 2016. The survey focused on
consumers’ eating habits of Baltic herring and salmon in
four Baltic Sea countries: Denmark, Estonia, Finland, and
Sweden (Fig. 1). The questionnaire was designed and the
results analysed by the authors, but the survey was admin-
istered by a professional market research company
Taloustutkimus oy, which has an established internet
panel since 1997. The survey company recruited over 500
consumers from each country (total 2117) to respond to
the survey questionnaire, which is above the required
sample size to allow generalization of the results to each
case country studied (with a 95% confidence level and 5%
margin of error) [10]. The survey was targeted to the adult
population, i.e. 18 years or older.
The survey questionnaire comprised 32 questions, in-
cluding sociodemographic questions as well as questions
relating to the frequency and amount of fish consump-
tion in general, and to Baltic herring and salmon in par-
ticular. There were also questions about reasons to eat
or to not to eat those species, and policies that may
affect the amount eaten. The questionnaire was trans-
lated into the national language of each case study coun-
try (Finnish, Swedish, Estonian and Danish). The
country and gender of the respondents were provided
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directly by the internet panel and were therefore not in-
cluded in the questionnaire.
Only those respondents who reported fish consump-
tion in general were asked follow-up questions about
herring and salmon consumption, and are included in
the analysis presented in this paper. As the survey fo-
cused specifically on the consumption of herring and
salmon originating from the Baltic Sea, a distinction had
to be made in the questionnaire between Baltic herring
and herring originating from elsewhere, e.g. the North
Sea or North Atlantic, as well as between the salmonids
(Baltic and Norwegian salmon, farmed salmon, rainbow
trout). With regard to herring consumption, those re-
spondents that reported eating some type of herring
were asked explicitly whether they consumed Baltic her-
ring. Concerning Baltic salmon, the respondents were
asked to choose the fish that they consumed from a list
of salmonids. The survey was designed and conducted
for the purposes of this study and another study investi-
gating consumers’ perception and consumption of fish.
The latter study [11] was published first, and it contains
a more detailed description of the study methods, in-
cluding the questionnaire.
Individual long-term fish consumption (in kilograms
per year) was estimated from the questions about con-
sumption frequency and amount. Consumption distribu-
tions were produced for subgroups defined by country,
gender, and age by random sampling (with replacement)
of the individual estimates. People’s reactions to changes
in policies or fish market (e.g. what if fish consumption
is recommended or restricted; what if the availability
and usability of these species improve; what if the price
of fish changes) were predicted based on their answers.
These decision scenarios were used to alter the
business-as-usual scenario and compare results between
scenarios.
Fig. 1 Countries where the BONUS GOHERR consumption survey was performed. Modified
from https://commons.wikimedia.org/wiki/File:Blank_map_of_Europe_-_Atelier_graphique_colors_with_Kosovo.svg
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In addition, a few technical scenarios were developed:
what if nobody ate more fish than ca. 1 kg per year; and
what if fish are considered as a primary versus a second-
ary source of nutrients. The latter scenario is important
if dose-responses are non-linear, as is the case with vita-
min D. In such a case, the incremental health benefits of
a primary source may differ from those of a secondary
source.
The data analysis was conducted using R software
(version 3.5.3, http://cran.r-project.org). Because the sur-
vey was conducted on an internet panel rather than on a
random sample from the general population, the respon-
dents may not be fully representative of the actual popu-
lation distributions in the countries. Therefore, the
respondents were weighted based on actual age, gender,
and region distributions of each country to produce
population representative results.
To support transparency, the anonymised data and all
the results will be available online: http://en.opasnet.org/
w/Goherr:_Fish_consumption_study
Concentrations
Fish-size-specific PCDD/F and dioxin-like PCB concen-
tration distributions for each fish species and country
were estimated based on EU Fish II study [12]. The re-
sults were based on pooled and individual fish samples
(98 Baltic herring and 9 salmon samples) and analysed
for 17 dioxin and 37 PCB congeners. A hierarchical
Bayesian module was developed with the JAGS package
of R software. The model assumed ca. 7% annual de-
crease in dioxin concentrations, based on long time
trends measured in Finland. The fish samples were
caught between 2009 and 2010.
The concentrations in Baltic herring were noted to be
highly sensitive to fish size, whereas size-dependency
was much weaker in salmon. Herring sizes in different
scenarios came from a fish growth model developed in
BONUS GOHERR project [13].
The fish samples came mostly from the Bothnian Sea,
which is an important catchment area for the Finnish
and Swedish fisheries. The concentration distributions
for the studied countries were derived from the concen-
tration model results by scaling them with the average
concentration on a catch area of interest relative to the
average from the Bothnian Sea. The Danish catch areas
were assumed to be Baltic west of Bornholm whereas
the Estonian catch area was the Gulf of Finland. The
Swedish catch areas for herring and salmon were as-
sumed to be the Baltic Main Basin and the Bothnian Sea
and Bay, respectively. The area selection was based on
landing statistics provided by the International Council
for the Exploration of the Sea (ICES) [14, 15].
Dioxin and PCB concentrations were weighted and
summed up to toxic equivalency quantities (TEQ) by
using WHO 2005 toxic equivalency factors (TEF) [16].
Levels of fatty acids and vitamin D in Baltic herring were
based on measurement data obtained from the Finnish
Food Safety Authority, and those in salmon are based on
the Fineli food database [17]. Methylmercury concentra-
tions were based on the Kerty database [18].
Exposures
Exposures to pollutants and nutrients were simply prod-
ucts of consumption amounts as assessed from the sur-
vey and concentrations in the consumed fish, with
possibly an uncertain background intake from other
sources. One exception to this was the exposure by in-
fants to dioxins and methylmercury during pregnancy
and breast-feeding; these were derived from the mother’s
exposure using toxicokinetic models.
Infant’s exposure during pregnancy and breast-feeding
was estimated with this equation:
Cs;i ¼
Ia;mt1=2;m f mFE
ln2BFi ; :
PðaÞ ¼ ð1−0:65ð1þ −0:39c
cþ 10pg=gÞÞ
2a
BoDi ¼ BoDPAFi ¼ BoD f i
RRi−1
f iðRRi−1Þ þ 1
; or
BoDi ¼ NiLDw ¼ P f iURiEiLDw
VOI ¼ EðmaxiðUðdiÞÞÞ−maxiðEðUðdiÞÞÞ;
where Cs,i = serum (s) concentration of dioxins in the
infant (i) in pg/g fat; Ia,m = average daily intake of dioxins
of the mother (m) in absolute (a) amounts pg/day;
t1/2,m = the half-life of dioxins in the mother (2737.5 d =
7.5 a); fm = fraction of ingested dioxins actually absorbed
from the gut of the mother (0.80); FE = fraction of
mother’s dioxin load that is transported to the infant
during breast feeding (0.25); BF = body fat amount in the
infant (into which the dioxins are evenly distributed)
during the period when tooth and testis are sensitive to
defects and the exposure is at its highest (ca. 6 months
of age) (1 kg) [19].
Exposure-responses
Several benefits and risks were assessed (Table 1). We
tried to choose impacts that are arguably large enough
that could affect the benefit-risk balance. The effects of
omega-3 fatty acids on coronary heart disease, mortality
and child’s intelligence, as well as the effects of vitamin
D on vitamin deficiency belong to this category. In con-
trast, there are several endpoints that have been linked
to fish or omega-3 intake, but they were not included
because current evidence is controversial: diabetes [32],
prostate cancer [33], asthma [34], and stroke [24].
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In addition, many studies have linked health benefits
to fish consumption rather than to a specific nutrient
[35]. We included depression [28], breast cancer [26],
and all-cause mortality [27], because the results have
been rather consistent in the meta-analyses. In summary
statistics, CHD and breast cancer mortalities were sub-
tracted from all-cause mortality to avoid double-
counting.
The dioxin effect on sperm concentratio n[6] and
methylmercury effect on intelligence in children [36] are
the most sensitive risks of these pollutants, and they
were therefore included.
In addition, we included some other dioxin effects.
Tolerable weekly intakes from 2001 and 2018 were in-
cluded for comparing methods of quantitative benefit-
risk assessment (based on a single health aggregate,
DALY) and more qualitative benefit-risk assessment
(based on assessing whether a beneficial or harmful
threshold is exceeded). A cancer effect was included be-
cause the news media often refers to dioxins as “the
super poison causing cancer” although researchers have
believed for years that it is the developmental problems
rather than cancer risks that are more relevant; a quanti-
tative assessment could give guidance to media commu-
nication. Finally, tooth defects were included because it
is a sensitive dioxin endpoint, but no study has com-
pared its magnitude to effects on sperm quality. Interest-
ingly, some of the key papers assessing this effect had
been conducted in Finnish mothers who had been ex-
posed to dioxins, mostly from Baltic herring [2, 21, 37].
The exposure-response function of methylmercury was
a synthesis of EFSA tolerable weekly intake and a linear
function from Cohen et al. [30]. This was necessary be-
cause although the EFSA estimate is fairly recent, it does
not quantify the magnitude of the effect if the TWI is
exceeded. The function by Cohen was based on concen-
trations measured from mothers’ hair. A conversion from
hair concentrations to daily exposures was performed ac-
cording to U.S.EPA [36].
We derived the exposure-response functions for infer-
tility and tooth defects indirectly from published results,
and thus the rationale of those endpoints will be de-
scribed here in more detail.
In humans, sperm concentrations have been shown to
decrease permanently if boys are exposed to dioxins be-
fore they are 9 years old. This data originates from
Seveso [38, 39] and a Russian children’s study [20].
EFSA recently assessed this risk from the Russian chil-
dren’s study and concluded that a significant effect was seen
already in the second quartile with a median PCDD/F TEQ
Table 1 Exposure-response functions used in the assessment
Exposure agent Response Esposure-
response
unit
Exposure-response
function mean (95%
confidence interval)
References and notes
TEQ (intake through
placenta and
mother’s milk)
male infertility due to
sperm concentration
decrease
pg /g in
boy’s body
fat
linear; slope 0.00006 (−
0.000019, 0.00014)
Based on EFSA TWI assessment [6]. Mother’s exposure
must be converted to child’s exposure (measured as
pg /g fat) [20]
TEQ (intake through
placenta and
mother’s milk)
developmental tooth
defects
log (pg /g)
in child’s
body fat
linear; slope 0.0014
(0.00029, 0.0025)
epidemiological study in Finland [21]
TEQ cancer morbidity pg/kg/day linear; slope 0.00051
(0.000026, 0.00097)
U.S.EPA dioxin risk assessment [22].
TEQ tolerable weekly intake
2001
pg/kg/week acceptable range below 14 EC Scientific Committee on Food recommendation
[23]
TEQ tolerable weekly intake
2018
pg/kg/week acceptable range below 2 EFSA recommendation [6]
Omega-3 fatty acids coronary heart disease
mortality
mg/day ED50: −0.17 (− 0.25, −
0.091)
Cochrane review [24]
Vitamin D vitamin D
recommendation
μg/day acceptable range 10–100 a step function based on the daily intake
recommendations for adults in Finland [25]
ALA coronary heart disase
mortality
mg/day RR 0.95 (0.72–1.26) after 1000mg/d of alpha-linolenic acid intake;
Cochrane review [24]
Omega-3 fatty acids breast cancer mg/d RR 0.95 (95% CI 0.90, 1.00) after 0.1 g/d of marine omega-3; a meta-analysis [26]
Fish all-cause mortality g /d RR 0.88, (95%CI 0.83, 0.93) after 60 g/d of fish; a meta-analysis [27]
Fish depression g/d RR 0.83 (95% CI 0.74, 0.93) after 35 g/d of fish; a meta-analysis [28]
Methylmercury loss in child’s IQ points mg/kg/day linear; slope 6.6 (− 0.27, 14) a synthesis of EFSA TWI estimate [29] and a previous
risk assessment [30].
DHA loss in child’s IQ points mg/day linear; slope − 0.0013 (−
0.0018, − 0.00081)
a previous risk assessment [31].
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concentration of 10.9 pg/g fat, when measured from the
serum of the boys at the age of ca. 9 years’ old. Mean sperm
concentration was ca. 65 (95% CI 50–80) million/ml in the
lowest quartile, while in all other quartiles, the concentra-
tion was ca. 40 (95% CI 30–55) million/ml. Due to the
shape of the effect, we used a non-linear exposure-response
curve with half of the maximum effect (effective dose 50,
ED50) occurring at a TEQ concentration of 10 pg/g fat.
However, a reduced sperm concentration as such is not
an adverse health effect. It only manifests itself if the con-
centration is low enough to prevent conception in a rea-
sonable time window, e.g. 5 years. According to a review,
the success rate of couples who try to have a child is 65%
in 6months if the male’s sperm concentration is above 40
million/ml [40]. Below that concentration, the probability
is rather proportional to the sperm concentration.
Based on this, we estimated that (assuming independent
probabilities between 6-month periods), the probability of
not becoming pregnant in 5 years follows this curve:
P infertility after 5 að Þ ¼ ð1−0:65 ð1þ ð−0:39cÞ
=ðcþ 10 pg=gÞÞÞ10;
where c is the dioxin concentration in pg/g in the
boy’s fat tissue and a is the follow-up time in years (in
this case, 5). This curve is rather linear below a TEQ
concentration 50 pg/g with slope ca. 0.00006 g/pg, mean-
ing that for each 1 pg/g increase in the dioxin concentra-
tion in the boy’s fat tissue (or serum fat), there is an
incrementally increased probability of 0.00006 that he
cannot father a child even after 5 years of trying.
The exposure-response function for the tooth defect
was also derived from several studies. Alaluusua and
coworkers have studied dioxin exposure in small chil-
dren and the development of permanent molar teeth.
They have found defects in both the general population
in Finland attributable to the exposures in the 1980’s
[21, 37] as well as in children exposed during the Seveso
accident [41].
Based on these studies, we approximated that the ef-
fect would be linearly correlated with the logarithm of
the dioxin concentration in the child.
Disease burden
Disease burden [42] was estimated in one of two alterna-
tive ways (Fig. 2): if an exposure agent affects the burden
of a particular disease in relation to the background of
the disease, the attributable fraction of a particular com-
pound exposure was calculated. If the relationship was
not relative to background, the attributable number of
cases due to the exposure was estimated, and this was
multiplied by the years under disease per case and the
disability weight of the disease (Table 2.).
BoDi ¼ BoDPAFi ¼ BoD f  RRi−1ð Þ= f  RRi−1ð Þ þ 1ð Þ; or
BoDi ¼ NiLDw ¼ P f URiEiLDw;
where BoD is the burden caused by the disease under
study, i is an exposure agent affecting the risk of the dis-
ease, PAF is a population attributable fraction, f is the
fraction of the population that is exposed, RRi is the
relative risk that the population faces due to the studied
level of exposure to the exposure agent i (as compared
with a counterfactual scenario with no exposure), Ni is
the number of disease cases attributed to exposure agent
Fig. 2 Schematic diagram of the health impact assessment model used. Each blue node is a submodel, and arrows are functional relations. The
main equation of the relations is shown beside each node
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i, L is the duration of a disease incident, Dw is the dis-
ability weight of the disease (0 = perfect health, 1 =
death), P is the population size, UR is the absolute unit
risk, and E is the exposure to the agent.
Background disease burdens were needed for all-cause
and coronary heart disease mortality, as well as breast
cancer and depression; they were obtained from the In-
stitute for Health Metrics and Evaluation (IHME)
(Table 3.) [45]. The disease burden of a cancer case was
based on IHME data. Furthermore, disability weights
of diseases were based on their estimates, if avail-
able. Duration estimates of diseases were mostly
based on the time window considered (1 year) or
lifetime (in the case of permanent infertility, tooth
or IQ effects due to infant exposure). We tried to be
realistic with estimates but also not to underestimate
the risks of fish consumption, so that potential con-
clusions about the safety of fish would not be
unfounded.
With the non-typical health effects, namely due to ex-
ceeding tolerable weekly intakes and deviation from the
vitamin D recommendation, we used very wide uncer-
tainty distributions, as it was unclear how much weight
should be given to endpoints that are only indications of
a potential health risk rather than actual adverse effects.
A value of information analysis was performed to test
the importance of these uncertainties.
Childlessness can be viewed as tragedy of life, so the
disability weight could be in the order of 0.1 DALY per
year permanently (50 years). However, the disability
weight applies to only half of the children (boys). There-
fore, we used 0.1*50*0.5 DALY/case = 2.5 DALY/case,
with a rather high uncertainty (0–5 DALY/case).
Population data for each country for year 2016 was
available from the Eurostat database. Data was sepa-
rated for gender and age (18–45 years and > 45 years)
groups [46].
Value of information analysis
Value of information is a mathematical method that
compares the difference of utility (money, DALYs or
other measure of the objective) in two scenarios: that
some additional information is obtained before a deci-
sion is made, or that the decision is made with the
current information. This can be formulated as
VOI ¼ E maxi U dið Þð Þð Þ−maxi E U dið Þð Þð Þ;
where VOI is value of information, E is expected value,
U is the utility of decision d, and i is an index of decision
options [47]. In this study, we also estimated the value
of including or excluding an option in the decision
making.
Table 2 Case burdens of different health responses. Case burden is calculated as the product of disease-specific disability weights
and disease durations
Response DALYs per case Description
Tooth defect 0–0.12 disability weight 0.001 and duration 60 a (years) with 100% uncertainty. For comparison, IHME gives disability
weight 0 for asymptomatic caries and 0.006 for mild other oral disorders with symptoms [43].
Cancer 19.7 (17.8–21.8) based on breast cancer, from IHME [44]
Vitamin D
intake
0.0001–0.01 disability weight 0.001 and duration 1 a with 100-fold log-uniform uncertainty
TWI 2001 0.0001–0.01 disability weight 0.001 and duration 1 a with 100-fold log-uniform uncertainty
TWI 2018 0.0001–0.01 disability weight 0.001 and duration 1 a with 100-fold log-uniform uncertainty
Infertility 0–5 disability weight 0.1 and duration 50 a with 100% uncertainty. See also text. Here we used a clearly higher
disability weight than IHME (0.008) [43].
Child’s IQ 0.11 (95% CI
0.06–0.16)
Mild intellectual disability (IQ < 70) has disability weight 0.043 (95% CI 0.026–0.064) based on IHME [43]. This is
scaled to one IQ point with duration 75 a.
Table 3 Total burden of disease of selected causes from all risk factors in the study countries [44]
Disease 1000 DALYs per year, mean (95% CI)
Denmark Estonia Finland Sweden
Breast cancer 20 (11, 30) 3.9 (2.5, 5.6) 16 (10, 23) 30 (18, 42)
Depression 21 (18, 25) 7.6 (6.4, 8.8) 33 (27, 38) 62 (51, 73)
Heart (CHD) 84 (79, 88) 54 (47, 61) 150 (140, 160) 200 (190, 210)
Mortality 810 (780, 840) 250 (240, 270) 800 (770, 830) 1200 (1180, 1250)
Vitamin D intake 2.1 (0.11, 9) 0.5 (0.026, 2.1) 2.1 (0.11, 8.8) 3.7 (0.19, 16)
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Fig. 3 Cumulative concentration distributions of the four key exposure agents in Baltic herring and salmon. For dioxin, also the decreasing time
trend since 1990 is shown. Concentrations of compounds in Baltic fish
Fig. 4 Cumulative fish consumption distributions of Baltic herring and salmon in different subgroups of the studied countries. The mean of each
distribution is shown with a circle. Consumption of Baltic fish by country and subgroup
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Results
Concentration distributions of the key exposure agents
in Baltic herring and salmon are shown in Fig. 3. Baltic
herring have lower concentrations than salmon for most
of the exposure agents studied, but for vitamin D, the
levels in salmon are lower. Dioxin concentrations have
declined substantially since 1970; the trend since 1990 is
shown in Fig. 3.
Fish consumption varies extensively between countries
and population subgroups, and also within each sub-
group (Fig. 4.). There is extensive individual variation
(almost a hundredfold) in fish consumption within most
subgroups.
Only about a quarter of people reported any wild Bal-
tic salmon consumption. Many people also say that they
do not know where their salmon comes from and
whether it is salmon or rainbow trout. Herring con-
sumption is more accurately known, although the Danes
are not sure whether their herring comes from the Baltic
Sea or the North Sea. For example, in Finland a typical
dish name contains the word herring (silakka in
Finnish), if it contains Baltic herring. Therefore the spe-
cies is often known to the consumer even if the dish is
not homemade. However, this is not true with Baltic
salmon.
There is also extensive variation between population
subgroups. Estonians eat clearly more Baltic herring and
Danes eat less than individuals from the other countries.
Males tend to eat more, and young people eat less than
other population subgroups. These differences are rather
similar in all countries, although at different levels. The
fraction of people that do not eat Baltic herring at all
varies remarkably between subgroups: it is only 25% in
old male Estonians, while it is more than 90% in young
female Danes. There is also a sizable fraction of people
who eat more than 3.6 kg/year (10 g/day) of Baltic her-
ring. This varies from a few percent in young people up
to about 30% in old Estonians.
The average consumption of Baltic herring and salmon
is 1.4 and 0.5 kg/a per person, respectively, in Finland
according to estimates based on our survey. However,
the Natural Resources Institute Finland has reported
(mostly based on catch-landing statistics) that the con-
sumptions of Baltic herring and salmon were 0.31 and
0.07 kg/a per person, respectively [48]. This implies that
people tend to overestimate their long-term average
consumption in general and for Baltic salmon in particu-
lar. Because of this discrepancy, we performed a sensitiv-
ity analysis where our consumption estimates were
scaled to match the Finnish statistics (data not shown).
The results of all variables were smaller, but the overall
picture remained the same. For example, a notable frac-
tion of population still exceeded the TWI 2018 value.
We also asked in the questionnaire how the respond-
ent would change his/her fish intake if an increase or de-
crease of fish consumption was recommended by the
Fig. 5 Individual change in consumption after policies to either increase or reduce fish intake. Individuals’ fish intake taking account of different
consumption policies
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authorities (Fig. 5.). The outcome depends on previous
consumption but not so much on the population sub-
group. If an increase is recommended, a clear and sys-
tematic increase is seen in the average response. In
contrast, a recommendation to reduce intake results in
inconsistent effects. Some people would follow the rec-
ommendation, but almost an equal number would not,
and most would not change their intake of fish. This
phenomenon is seen already at current intake levels
below 1.8 kg/year, which is the level consumed by most
of the population.
Because of the large variation in fish consumption, also
the dioxin exposure from Baltic fish varies by more than
a hundred-fold within the different population sub-
groups (Fig. 6.) and there is also extensive variation be-
tween the subgroups. In the model, many people have
apparently zero exposure because dioxin sources other
than Baltic fish were not included. A fraction ranging
Fig. 6 Cumulative dioxin (TEQ) exposure distributions shown by subgroup and country. The mean of each distribution is shown with a circle.
Exposure to dioxins from Baltic fish
Table 4 Burden of disease related to Baltic herring and salmon consumption
Response Exposure
agent
DALYs per year, mean (95% CI)
Denmark Estonia Finland Sweden
Cancer (all) TEQ 160 (0, 1300) 57 (0, 370) 150 (0, 1300) 260 (0, 2200)
Cancer (breast) Omega-3 − 310 (− 3700, 0) −55 (− 450, 0.002) −130 (− 1400, 0) − 330 (− 4000, 0)
Child’s IQ DHA −88 (− 1000, 0) −180 (− 1300, 0) − 58 (− 370, 0) − 540 (− 7600, 0)
Child’s IQ MeHg 390 (0, 1900) 170 (0, 1100) 56 (0, 270) 370 (0, 6100)
Depression Fish −130 (− 1200, 0) −79 (− 430, 0) − 170 (− 1300, 0) − 420 (− 3000, 0)
Heart (CHD) ALA 3.1 (− 220, 290) − 20 (− 150, 37) − 40 (− 560, 280) −47 (− 880, 510)
Heart (CHD) Omega-3 −190 (− 2600, 200) − 120 (− 1400, 69) −300 (− 2300, 120) − 530 (− 7300, 820)
Infertility TEQ 110 (0, 1100) 66 (−23, 410) 44 (0, 470) 75 (0, 460)
Mortality Fish −2200 (− 20,000, 0) −1200 (− 8300, 0) − 2800 (− 21,000, 0) − 5600 (− 44,000, 0)
Tooth defect TEQ 160 (0, 2400) 38 (0, 170) 11 (0, 130) 34 (0, 480)
TWI 2001 TEQ 400 (0, 6000) 87 (0, 1400) 180 (0, 2400) 460 (0, 6100)
TWI 2018 TEQ 690 (0, 7400) 310 (0, 2100) 660 (0, 5700) 1000 (0, 12,000)
Vitamin D intake Vitamin D −88 (− 490, 0) −42 (− 340, 0) − 59 (− 420, 0) −200 (− 1800, 0)
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from a few percent to a quarter exceed the EC Scientific
Committee on Food TWI value from 2001 [23]. The
fraction becomes much higher, from 20% to up to 75%,
when the new EFSA TWI value of 2 pg/kg/week from
2018 is used as the criterion [6].
The main objective of this study was to compare
health risks and benefits of Baltic fish consumption. The
most dominant feature is the health benefits from all-
cause mortality, ischemic heart disease, and depression
(Table 4). Figure 7. shows the large variation between
population subgroups. In old age groups, the benefits
clearly outweigh all risks but in most population sub-
groups, the benefits are typically much larger than risks.
In contrast, the risks and benefits in young women are
both small, but at the individual level, risks are often lar-
ger according to the model.
Figure 8 illustrates several different objectives that
could be used as a basis for decision making. The first
one is using a net health effect, estimated similarly to
the quantitative benefit-risk assessment performed here.
The second objective focuses only on young women as
the target group facing the risks, and ignores the impact
on others. The third and fourth objectives were to try to
avoid exceeding tolerable weekly intake values from
2001 and 2018, respectively.
When the whole population is considered (left bar),
the net health objective recommends increasing rather
than decreasing Baltic fish consumption in every coun-
try, while approaches based on TWI suggest that redu-
cing fish consumption is a better option. If only the
target population of young women is considered (sec-
ond-left bar), all impact values are close to zero, but the
net health impact may sometimes point to a slightly lar-
ger risk than benefit; the situation is ambiguous but the
stakes are not high.
In general, health impacts are much smaller in young
age groups, and in young women, the critical issues to
be considered are the effects on their children’s
intelligence quotient (IQ), tooth defects, and sperm con-
centration, not the health impacts on the woman herself.
These risks emerge due to dioxin and methylmercury
exposures during pregnancy and breast feeding. The
child’s own diet during his/her early years may also have
an impact, although the exposure then is typically much
lower. These risks are in the same range as the health
benefits, and the overall balance depends mostly on the
Fig. 7 Disease burden attributable to eating Baltic fish in Denmark, Estonia, Finland, and Sweden (expected value at the individual level). Note
that negative values refer to improved health. mDALY: 0.001 disability-adjusted life years, CHD: coronary heart disease, IQ: intelligence quotient.
Disease burden attributable to consumption of Baltic fish by country, group, and policy
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Fig. 8 Outcome of interest using different objectives. The default objective (the main assessment of this article) focusses on the total net health
effect in the whole population. The second objective focusses on young women only. Tolerable weekly intakes from 2001 and 2018 are
converted to DALYs based on the number of people exceeding the guidance value. Disease burden using different objectives
Fig. 9 Burden of disease of the most important environmental health factors in Finland. BONUS GOHERR results are from this study, other results
are from a previous publication [49]. Environmental disease burden in Finland
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disability weights of distinct outcomes and other value
judgements such as whether Baltic fish is considered as
a primary source of nutrients.
Based on our survey, a policy of recommending in-
creased consumption seems to be somewhat beneficial,
while a recommended consumption reduction is indis-
tinguishable from the business-as-usual scenario. In con-
trast, policy decisions and actions to reduce dioxin
emissions and consequently exposures have been very
effective during the last 40 years (see Fig. 3 for concen-
tration trends).
From a wider perspective, dioxins in Baltic herring and
salmon are only one of the many environmental health
hazards (Fig. 9.). For example, they pose a smaller risk
than methylmercury which is also present in fish, and
their risk is not even close to the largest health risks ori-
ginating from air pollution (which may be up to tens of
thousands DALY in Finland alone).
It is possible that we have been somewhat overopti-
mistic about the current sperm concentrations, as
reduction from subfertile background levels could in-
crease the probability of infertility more than predicted
in our model. Therefore, we conducted a sensitivity
analysis on men with decreased sperm concentrations
from an unrelated reason, which dioxins would be
likely to reduce even further. For example, if the sperm
concentration is 10 million/ml, the probability of infer-
tility in 5 years is 0.32 based on the equation shown
above. That increases to 0.4 at a dioxin concentration
of 10 pg/g. If 10 % of the population had such low
sperm concentration and if 20% of boys exceed 10 pg/g
(as seems to be the case according to our model), then
for example we would see in Finland 25,000 boys/year *
0.1 with low fertility * 0.2 with high dioxin * 0.08 abso-
lute increase in infertility = 40 cases per year, each 2.5
DALY and thus 100 DALY in total. This is more than
the 29 DALY estimated from the default model, but
does not change the overall picture in Fig. 9. The indi-
vidual risk per mother would be 0.1 and 0.03 mDALY/a
per person, respectively (compare to Fig. 7). They are
also much smaller than the 25,000 boys/year * 0.1 with
low fertility * 0.32 absolute probability of infertility
* 2.5 DALY = 2000 DALY due to infertility from all
other causes of low sperm concentration in our sensi-
tivity analysis.
IHME estimates the Finnish disease burden of male in-
fertility of all causes at only 52 DALY/a; when the value
includes female infertility, it is roughly doubled [44].
Thus, it seems that our estimates seem to overestimate
rather than underestimate the sperm concentration
problem.
Value of information was examined for specific deci-
sion scenarios, where a group of similar decisions were
considered together.
Value of information was calculated for the total bur-
den of disease in a random study country (Denmark,
Estonia, Finland, and Sweden were not weighted by
population), but using uncertainties for individual
people. This approach ensures that the value of informa-
tion is not underestimated, because at the population
level, many uncertainties average out and are smaller
than at the individual level.
The decision about recommending a small herring size
has practically no expected value of perfect information
(less than 1 DALY/a for a whole country) because
switching from large to small herring is a no-regret op-
tion; in fact, in most cases, it is better than the other
alternatives.
The decision about consumer policy (including im-
proved information, better availability and usability of
fish, and consumption recommendations) has an ex-
pected value of perfect information of 150 DALY/a, and
there is some uncertainty about what should be recom-
mended. The maximum net benefit is usually achieved
by increasing Baltic fish intake. Therefore, the most im-
portant decision option which needs to be incorporated
into the decision process is to increase factual informa-
tion and fish availability (there would be expected loss of
1600 DALY/a if that option was not considered).
The analysis was also performed for the young female
subgroup separately, assuming a situation where
subgroup-specific policies would be both feasible and ef-
fective and would not affect the other subgroups. The
expected value of perfect information was 190 DALY/a.
At the same time, the total disease burden at stake is
clearly smaller than with the whole population (see Fig.
7), because the disease burden from overall mortality
and heart disease is small among young women. These
two results together reveal that the uncertainties about
what to recommend with respect to young women are
clearly larger than with the other subgroups.
Discussion
Dioxin and PCB concentrations have been constantly
decreasing in Baltic fish for 40 years, and now they are
mostly below the EU limits. In addition, the consump-
tion of Baltic herring has been decreasing during the last
decades and is now less than a kilogram per year, vary-
ing between age groups (older people tend to eat more),
genders (males tend to eat more) and countries (Esto-
nians tend to eat more and Danes less than the three
other countries studied). People reported that better
availability of easy-to-prepare products, interesting rec-
ipes, and reduced pollutant levels would increase their
consumption of Baltic herring [11]. In contrast, recom-
mendations to reduce consumption on average would
have little effect.
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According to this study, the health benefits of Baltic
herring and salmon clearly outweigh health risks in
people in age groups over 45 years. The benefits are
similar to risks in the most vulnerable subgroup, women
of childbearing age. The balance depends on value as-
sumptions: risks prevail if exceeding the tolerable weekly
intake as such (especially the new 2018 value) is given
weight in the consideration. The analysis was robust in
the sense that we did not find factual uncertainties that
could significantly change the conclusions and would
warrant postponing decisions in the hope of gathering
new crucial information.
The largest health benefits originates from reduced all-
cause mortality, coronary heart disease, breast cancer,
and depression, and improved intelligence quotient of
the child of a woman who consumes fish. Each of these
effects has been linked to either fish in the diet or more
specifically to omega-3 fatty acids, implying that a full
palette of benefits is not available only from food
supplements.
The risk of methylmercury to lower a child’s IQ ap-
peared to be as large, or even larger, than all dioxin risks
combined (Table 4). In fact, it is a common misconcep-
tion that dioxins pose the largest risk if one eats Baltic
fish. In addition, the dioxin-related cancer risk was not
larger than the risk of developmental effects despite the
fact that dioxins are reputed to be potent carcinogens.
There seems to be room for an updating of the risk
communication about consumption of Baltic fish. This
analysis suggests that dioxins are not the largest health
risk related to these fish; and that the dioxin-related can-
cer risk is small in everyday life. The facts that dioxins
are very potent per microgram of substance and that
they cause cancer in laboratory animals after high doses
[1] are irrelevant details in risk communication and in-
stead, they provide a wrong impression of the actual
risks to an individual’s health.
We found some no-regret policies. Promoting the con-
sumption of small Baltic herring rather than large ones
confers all of the health benefits but reduces the individ-
ual’s exposure to pollutants. Promoting the consumption
of Baltic fish to population subgroups other than young
females confers more health than harm. Finally, reducing
dioxin emissions into the atmosphere will reduce con-
centrations not only in fish but also in dairy and meat
products.
One critical question about this assessment is whether
the beneficial effects are actually real and causal. The re-
cent Cochrane review concluded that there is little if any
cardiovascular benefit from omega-3 supplements [24].
Aung et al. conducted a meta-analysis of omega-3 sup-
plement trials with more than 77,000 individuals [50].
They found only weak, border-marginal cardiovascular
benefits and concluded that the analysis did not support
the use of dietary omega-3 supplements. The US NCCIH
has also commented on these studies: “Moderate evi-
dence has emerged about the health benefits of eating
seafood. The health benefits of omega-3 dietary supple-
ments are unclear.” [51].
Indeed, omega-3 supplements may not affect diet
composition, but each fish meal replaces another meal
of some kind. These other dietary changes complicate
estimates on the impacts of a specific nutrient. There-
fore, it is warranted to look at epidemiological meta-
analyses on fish consumption as a whole. Fish consump-
tion has been reported to exert clear beneficial effects on
all-cause mortality [27] and depression [28]. In contrast,
marine omega-3 fatty acids, but not fish consumption,
was linked to a reduced risk of breast cancer [26]. It
seems plausible that not all of the effects are mediated
specifically by omega-3 fatty acids, but that fish likely are
sources of several beneficial nutrients and should be a
part of healthy diet i.e. it is probably over-simplistic to
claim that one compound is the source of all of the
benefits.
Elizabeth Pennisi discussed several studies about the
genetic variation of fatty acid metabolism and its links to
cardiovascular risk [52]. The overall conclusion is that al-
though these issues are not completely understood, there
seems to be genetic variations in the health benefits of
omega-3 fatty acids. Lauritzen et al. conducted a review
on docosahexaenoic acid (DHA) and concluded that it
was especially important for the developing brain during
the fetal period and infancy, although there may be vari-
ation in intrinsic production and therefore in the need to
obtain DHA from the diet [53]. This also implies that
there can be complex variations within the population.
Irrespective of the actual cause, several beneficial ef-
fects from fish consumption make the case stronger:
even if one endpoint turns out to be less important than
previously thought, as has recently happened with
omega-3 supplements and cardiovascular health, it is
still unlikely that all of these results are false positives. In
this assessment, we used the Cochrane best estimate of
the omega-3 effect, which was described as “little, if any
use for cardiovascular disease prevention”. Interestingly,
the benefit was still larger than the risks associated with
dioxin from the same fish. This result emphasizes the
importance of quantitation and context: what is “small”
depends on what it is being compared against.
A previous benefit-risk assessment was performed on
omega-3 fatty acids and dioxins [54]. The study found
scenarios where consumption of herring in the
Netherlands would confer the benefits of omega-3 but
dioxin exposure would remain below the tolerable intake
at that time (14 pg/kg/week).
Another study concluded that Atlantic herring pro-
vided cardiovascular health benefits at consumption
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levels where the dioxin cancer risk remained acceptable
[55]. A Chinese study also concluded that herring con-
taining PCB7 concentrations 12.5 ng/g fresh weight
could be used regularly and would confer health benefits
without significant risks linked with the contaminants
[56]. This is equivalent to approximately 2–3 pg/g fresh
weight of TEQ, assuming that the PCB7/TEQ ratio is
similar in Finnish and Chinese herring.
However, the National Food Agency of Sweden
published a report which concluded that increased
herring consumption would unnecessarily increase di-
oxin risks, since it would be possible to eat fish with
less dioxins (e.g. smaller herring or other species) and
still gain the same health benefits [57]. The report
did not assess how consumption would change in
practice, if Sweden abandoned its exemption to use
large herring.
None of these benefit-risk assessments compared the
magnitude of risks and benefits quantitatively by apply-
ing a common scale such as DALY. A more common
approach has been to compare exposure estimates from
a study to an administrative threshold. Clear conclusions
can be drawn if the risks are below and the benefits
above their respective thresholds, or vice versa. However,
this approach is dubious in situations where there is a
need for quantitative comparison of risk and benefits.
According to our experience, a threshold-type
exposure-response function leads to a tendency to use
the threshold as a strict guideline for action. This leads
to inefficient allocation of resources, as it is unlikely that
the risks would abruptly increase or benefits decrease.
In contrast, a quantitative benefit-risk assessment at-
tempts to estimate the total benefits and total risks and
then to compare these two values. In this approach, it is
necessary to estimate all relevant endpoints, even if there
is uncertainty about the mere existence of a causal effect.
There is a reason for adopting this approach: if an uncer-
tain endpoint is rejected from further scrutiny, mathemat-
ically it implies certainty about zero impact. Therefore, on
the one hand, it is necessary to avoid omissions and try to
produce a balanced quantitative view of both risks and
benefits, and on the other hand, of their uncertainties.
This is also important for risk communication and risk
perception. If all hazards are just “risky” or “not risky”,
people fail to appreciate that some risks are worse than
others. For example, our whole fish benefit-risk assess-
ment shines an illustrative light when compared with
other major environmental health risks: maybe it is not
worth worrying too much if it draws attention away
from more serious risks. Having said that, it should be
remembered that even small risks are worth reducing if
the costs of reduction are low or even negative.
The recent EFSA TWI recommendation for dioxins (2
pg/kg/week as compared with the previous TWI 14 pg/
kg/week) dramatically increases the fraction of the popu-
lation who are non-compliant in all four countries stud-
ied here. However, the implications of this policy
decision are far from clear and require further discus-
sion. We encourage both researchers and administrators
to pay much more attention to comparing risks and ben-
efits instead of only considering risks isolated from real,
complex situations [58]. In fact, our results raise several
questions.
First, the most sensitive outcome, namely the decrease
in the sperm concentration, is only relevant for young
women whose future children may be affected. In this
respect, should the TWI be applied to all population
subgroups?
Second, as dioxin exposure strongly relates to a diet
consisting of otherwise healthy Baltic fish (especially Bal-
tic herring) in the Nordic countries, should these health
benefits be considered when changes to dioxin policy
are announced? For example, the Swedish food safety
authority did not raise this issue in their commentary
about the new EFSA TWI [59].
Third, Baltic herring have also other important values
in addition to their effects on health: there are the fol-
lowing factors that should not be ignored 1) economic
(Baltic herring is the most abundant catch species by
weight from the Baltic Sea), 2) ecological (sustainable
yield of Baltic herring is large and the catch removes nu-
trients from the sea), 3) climate (Baltic herring could re-
place red meat and other climate-unfriendly food
sources), 4) social (Baltic herring is an inexpensive local
food), and 5) cultural (Baltic herring and salmon are an
important part of coastal culture) [60, 61]. Moreover,
Baltic herring has value for food security [5, 11, 62].
Should these values be considered when a dioxin policy
is being devised? The BONUS GOHERR project found
that all of these issues are considered important in our
twenty-first century society [63, 64].
The results of the study should not be considered as
exact magnitudes of the properties studied. We
attempted to quantify real, measurable properties but ac-
knowledge that these are just our best estimates of the
actual truth, sometimes produced with only marginal
data. We also tried to use probability distributions in a
systematic manner to minimize any bias and also to take
account of actual variations in populations. We had to
make several assumptions e.g. about actual impacts of
policies, how representative Finnish measurements are
for fish in other countries, what background exposures
to use, and how to derive disability weights or durations.
Furthermore, we had to convert all outcomes into a sin-
gle metric for policy and value-of-information analyses,
and for this purpose, DALY seemed to be most feasible.
We had to stretch the definition slightly to include non-
disease outcomes, and we also had to use author
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judgement to estimate the impacts of competing risks,
which are not directly observable from epidemiological
data. Previous assessments have shown large health ben-
efits related to fish, but since there is some uncertainty
associated with these claims, we tried to be realistic but
also tried to avoid underestimating risks, because that
bias might weaken the arguments about safety of fish.
We have made the data, code, and reasoning available
on Opasnet to facilitate the work of potential critics to
find mistakes and false interpretations and also offer a
place to publish comments and criticism. A quantitative
benefit-risk assessment can actually be seen as one step in
an iterative and collaborative process, where the under-
standing improves as other researchers make their own
assessments, resulting in updated evaluations for use in fu-
ture studies. Quantitative benefit-risk assessments would
offer material for realistic discussions about making in-
formed compromises between risks and benefits.
This study was not designed to answer value-based
questions but it was able to identify some interesting
points. The value of information was low for the
remaining scientific uncertainties about dioxin risks, and
the critical questions are related to the value questions
mentioned above. Of course, dioxin sources and concen-
trations vary in different parts of Europe as well as in
other parts of the world, but because of biomagnifica-
tion, fish are invariably a typical source of many persist-
ent pollutants. Political discussions and deliberation are
needed about risk-benefit comparisons. Scientific facts
are crucial, but they are not the only crucial elements in
that discussion.
Conclusions
In conclusion, despite the new evidence and at odds
with the new EFSA TWI recommendation, this study in-
dicates that Baltic fish are still a safe and healthy food
for most population subgroups in the Nordic countries.
A distinct subgroup, namely young women planning to
have children, is of special concern. The health benefits
in this subgroup are smaller than in the older age
groups, and also there are potential but small risks to a
child that is exposed during pregnancy and breast feed-
ing. Experts do not agree on conclusions about this sub-
group, but the scientific uncertainties actually do not
play a large role. In contrast, value judgements are cru-
cial when designing policies related to the dioxin prob-
lem of Baltic fish. These questions should be carefully
discussed and deliberated by decision makers, experts,
citizens, fishermen/women, and other stakeholders.
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